N
NEOGAP Therapeutics
Biotech & Life Sciences · Stockholm, Sweden · Founded 2016
Imagine if cancer patients who lack efficient treatment options could be cured MoreLess
Developer of personalized cancer immunotherapy designed to precisely target and eliminate cancer. The company's product identifies optimal neoantigens to target, activate and multiply T-lymphocytes with the purpose of eradicating cancer, enabling cancer patients to recover from the disease. Keywords: Pharmaceuticals and Biotechnology, Biopharmaceutical Producer, Biopharmaceutical Research, Cancer Cure Therapy, Immune System, Immuno-Oncology Drugs, Immunotherapy Drugs, Pharmaceutical, Pharmaceutical Medicine.
Talent graph
NEOGAP Therapeutics's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on NEOGAP Therapeutics's cap table
Sourced from Dealroom's funding and investor records.


Global footprint
Where NEOGAP Therapeutics has talent and traffic
team presence
Market sentiment
What the market is saying about NEOGAP Therapeutics
An AI-synthesized read of the highest-engagement posts about NEOGAP Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NEOGAP Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.